Kansas City Cancer Center

Overland Park, Kansas 66210

0 studies enrolling now · 10 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Locally Recurrent Breast Cancer, Lung Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma, NSCLC, Non Small Cell Lung Carcinoma, Soft Tissue Sarcoma

Studies at this site

• Phase 3 Study to Treat Patients With Soft Tissue Sarcomas — Completed
• The BEACON Study (Breast Cancer Outcomes With NKTR-102) — Completed
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL — Withdrawn before enrolling
• A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma — Completed
• Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer — Completed
• A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer — Completed
• Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer — Completed
• Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma — Completed
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed